Graves Hyperthyroidism After Stopping Immunosuppressive Therapy in Type 1 Diabetic Islet Cell Recipients With Pretransplant TPO Autoantibodies

OBJECTIVE: After an initially successful islet cell transplantation, a number of patients return to C-peptide negativity, and therefore immunosuppressive therapy is discontinued. Some are then found to have developed Graves disease. We examined the risk of Graves disease after immunosuppression. RES...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillard, Pieter, Huurman, Volkert, Van der Auwera, Bart, Decallonne, Brigitte, Poppe, Kris, Roep, Bart O., Gorus, Frans, Mathieu, Chantal, Pipeleers, Daniel, Keymeulen, Bart
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752930/
https://www.ncbi.nlm.nih.gov/pubmed/19549735
http://dx.doi.org/10.2337/dc08-2339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752930/
https://www.ncbi.nlm.nih.gov/pubmed/19549735
http://dx.doi.org/10.2337/dc08-2339

Ejemplares similares